X0306 4 2018-05-02 1 0001609550 Inspire Medical Systems, Inc. INSP 0001584404 Jain Mudit K. C/O INSPIRE MEDICAL SYSTEMS, INC. 9700 63RD AVENUE NORTH, SUITE 200 MAPLE GROVE MN 55369 1 0 1 0 Common Stock 2018-05-07 4 C 0 741494 A 741494 I See Footnote Common Stock 2018-05-07 4 C 0 419663 A 1161157 I See Footnote Common Stock 2018-05-07 4 C 0 195465 A 1356622 I See Footnote Common Stock 2018-05-07 4 C 0 272391 A 1629013 I See Footnote Common Stock 2018-05-07 4 C 0 466494 A 2095507 I See Footnote Series B Convertible Preferred Stock 2018-05-07 4 C 0 3998154 0 D Common Stock 741494 0 I See Footnote Series C Convertible Preferred Stock 2018-05-07 4 C 0 2790760 0 D Common Stock 419663 0 I See Footnote Series D Convertible Preferred Stock 2018-05-07 4 C 0 1299847 0 D Common Stock 195465 0 I See Footnote Series E Convertible Preferred Stock 2018-05-07 4 C 0 1576336 0 D Common Stock 272391 0 I See Footnote Series F Convertible Preferred Stock 2018-05-07 4 C 0 3102190 0 D Common Stock 466494 0 I See Footnote Employee Stock Option (right to buy) 16.00 2018-05-02 4 A 0 17296 0 A 2028-05-02 Common Stock 17296 17296 D Shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1855 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. Shares of Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation). These shares had no expiration date. Shares of Series E Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1728 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation). These shares had no expiration date. These shares are held of record by Synergy Life Science Partners, LP ("Synergy"). Synergy Venture Partners, LLC ("SVP LLC") serves as the sole General Partner of Synergy. As such, SVP LLC possesses sole voting and investment control over the securities owned by Synergy, and may be deemed to have indirect beneficial ownership of the securities held by Synergy. SVP LLC, however, owns no securities of the Issuer directly. Mr. Jain, a director of the Issuer, is a Manager of SVP LLC and shares voting and dispositive power over the shares held by Synergy. Mr. Jain disclaims beneficial ownership of the shares held by Synergy except to the extent of his proportionate pecuniary interest therein. The option vests and becomes exercisable on May 2, 2019, subject to the Reporting Person's continuous service to the Issuer through such date. The option was erroneously included on the Reporting Person's Form 3 filed on May 2, 2018. /s/ Richard Buchholz, as Attorney-in-Fact for Mudit K. Jain 2018-05-09